SL Science Holding Ltd (NASDAQ: SLBT) is a Healthcare company (Biotechnology) with a market capitalization of $356M. The Maz Rating grades it against the other companies in its sector.
SL Science Holding Ltd's current Maz Rating and its five factor grades are for members: log in to see them.
At $0.64, SL Science Holding Ltd trades at 169.3x sales. Over the last twelve months it generated about $2M of revenue. It runs a gross margin of 35.3%, an operating margin of -174.6% and a net margin of -173.8%. It shows return on equity of -95.4%, return on invested capital of -153.7% and a free cash flow yield of -0.6%. On the balance sheet: a debt-to-equity ratio of 0.09 and a current ratio of 3.05. Over the past 52 weeks the share price ranged from $0.62 to $14.50, with a beta of 0.09.
SL Science Holding Ltd does not currently pay a dividend.
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of June 2026, SL Science Holding Ltd (SLBT) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 128126.1% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 128126.1% / 33% · Receivables / Mkt Cap (36m) 2534.0% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 128126.1% / 33.33% · Receivables / Mkt Cap (24m) 2534.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 0.00% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 70.0% / 33.33% · Receivables / Avg Assets (4Q) 1.77% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 93.2% / 33.33% · (Cash+Recv) / Total Assets 95.1% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of June 2026, SL Science Holding Ltd (SLBT) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. SL Science Holding Ltd is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
SL Science Holding Ltd reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated June 30, 2026 (Q2 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.